Impact of COPD Treatment on Survival in Patients with Advanced Non-Small Cell Lung Cancer

Hyunji Jo, Sojung Park, Nam Eun Kim, So Young Park, Yon Ju Ryu, Jung Hyun Chang, Jin Hwa Lee

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Chronic obstructive pulmonary disease (COPD) is associated with a poor prognosis in patients with non-small cell lung cancer (NSCLC). However, the impact of COPD treatment on the survival of patients with advanced NSCLC remains uncertain. We retrospectively investigated COPD patients among patients newly diagnosed with advanced NSCLC between September 2005 and August 2019 at a university hospital. The clinical characteristics, lung function, and survival outcomes were analyzed and compared between patients who did and did not receive COPD treatment. Among 221 patients with advanced NSCLC and COPD, 124 patients received treatment for COPD and 97 patients did not receive treatment for COPD. Forced expiratory volume in 1 s (FEV1 ) % predicted value was greater in the no-treatment group than in the COPD treatment group (p < 0.001). The median overall survival (OS) of the treatment group was 10.7 months, while that of the no-treatment group was 8.7 months (p = 0.007). In the multivariate analysis, COPD treatment was independently associated with improved OS (hazard ratio 0.71, 95% confidence interval 0.53–0.95, and p = 0.021). COPD treatment was associated with improved OS in patients with advanced NSCLC and COPD. Therefore, pretreatment spirometry and maximal treatment for COPD may offer a chance of optimal management for patients with advanced NSCLC.

Original languageEnglish
Article number2391
JournalJournal of Clinical Medicine
Issue number9
StatePublished - 1 May 2022

Bibliographical note

Funding Information:
Funding: This work was supported by the National Research Foundation of Korea (NRF-2020R1A5A2019210). The funding source had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.

Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.


  • bronchodilator
  • chronic obstructive pulmonary disease
  • inhaled corticosteroids
  • non-small cell lung cancer
  • survival


Dive into the research topics of 'Impact of COPD Treatment on Survival in Patients with Advanced Non-Small Cell Lung Cancer'. Together they form a unique fingerprint.

Cite this